Cite
HARVARD Citation
Langley, R. et al. (2021). Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. Lancet. 397 (10274), pp. 581-591. [Online].